分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Protective role of small extracellular vesicles derived from HUVECs treated with AGEs in diabetic vascular calcification

Guo Bei, Shan Su-Kang, Xu Feng, Lin Xiao, Li Fu-Xing-zi, Wang Yi, Xu Qiu-Shuang, Zheng Ming-Hui, Lei Li-Min, Li Chang-Chun, Zhou Zhi-Ang, Ullah Muhammad Hasnain Ehsan, Wu Feng, Liao Xiao-Bo, Yuan Lin

Journal:JOURNAL OF NANOBIOTECHNOLOGY

IF:9.43

DOI:10.1186/s12951-022-01529-z

PMID:35842695

Published:2022-07-16

research field:分子生物学癌症研究细胞生物学信号转导代谢学

Abstract

The pathogenesis of vascular calcification in diabetic patients remains elusive. As an effective information transmitter, small extracellular vesicles (sEVs) carry abundant microRNAs (miRNAs) that regulate the physiological and pathological states of recipient cells. In the present study, significant up-regulation of miR-126-5p was observed in sEVs isolated from human umbilical vein endothelial cells (HUVECs) stimulated with advanced glycation end-products (A-EC/sEVs). Intriguingly, these sEVs suppressed the osteogenic differentiation of vascular smooth muscle cells (VSMCs) by targeting BMPR1B, which encodes the receptor for BMP, thereby blocking the smad1/5/9 signalling pathway. In addition, knocking down miR-126-5p in HUVECs significantly diminished the anti-calcification effect of A-EC/sEVs in a mouse model of type 2 diabetes. Overall, miR-126-5p is highly enriched in sEVs derived from AGEs stimulated HUVECs and can target BMPR1B to negatively regulate the trans-differentiation of VSMCs both in vitro and in vivo.Graphical Abstract

本文使用的Yeasen产品

购物车
客服
转染试用